ROYALTY PHARMA PLC 12/05/2025 AGM
1Allow Proxy SolicitationOppose
2Approval of Membership Interest Purchase Agreement, Share Issuances, and Amended ArticlesFor
3Advisory Vote on Executive Compensation That May Become Payable in Connection With the Membership Interest Purchase AgreementOppose
4Approve All Employee Option/Share SchemeFor
5Approve Terms for Share Repurchase AgreementsOppose
6aRe-elect Pablo Legorreta - Chair & Chief ExecutiveOppose
6bRe-elect Henry Fernandez - Senior Independent DirectorFor
6cRe-elect Bonnie Bassler - Non-Executive DirectorFor
6dElect Vlad Coric - Non-Executive DirectorFor
6eRe-elect Errol De Souza - Non-Executive DirectorFor
6fRe-elect Catherine Engelbert - Non-Executive DirectorFor
6gRe-elect David Hodgson - Non-Executive DirectorOppose
6hRe-elect Ted Love - Non-Executive DirectorOppose
6iRe-elect Gregory Norden - Non-Executive DirectorFor
7Advisory Vote on Executive CompensationOppose
8Re-appoint Ernst & Young LLP as the Auditors of the Company.Abstain
9Receive the Annual ReportFor
10Approve Remuneration PolicyOppose
11Approve the Remuneration ReportOppose
12Re-appoint Ersnt & Young LLP as the Auditors of the Company in the UKAbstain
13Allow the Board to Determine the Auditor's RemunerationFor
14Issue Shares with Pre-emption RightsFor
15Issue Shares for CashFor